Showing
1 - 3
results of
3
for search '
Masaquel, A.
'
Skip to content
Home
High Impact Articles
Search Options
UiTM Open Access
Search by UiTM Scopus
Advanced Search
Search by Category
Discovery Service
Sources
Jawi Collection
UiTM Journals
List UiTM Journal in IR
Statistic
About
Open Access
Creative Commons Licenses
COKI | Malaysia Open Access
Report Technical
User Guide
Contact Us
Search Tips
FAQs
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Author
Masaquel, A.
Showing
1 - 3
results of
3
for search '
Masaquel, A.
'
, query time: 0.03s
Refine Results
Sort
Relevance
Date Descending
Date Ascending
Call Number
Author
Title
1
Economic burden related to chemotherapy-related adverse events in patients with metastatic breast cancer in an integrated health care system
by
Rashid N
,
Koh HA
,
Baca HC
,
Lin KJ
,
Malecha SE
,
Masaquel
A
Published 2016-10-01
Get full text
Article
2
Cost-effectiveness of obinutuzumab versus rituximab biosimilars for previously untreated follicular lymphoma
by
Dawson, K.
,
Felizzi, F.
,
Guzauskas, G.F
,
Launonen, A.
,
Masaquel
,
A
.
,
Spencer, S.J
,
Veenstra, D.L
Published 2021
Call Number:
Loading...
Located:
Loading...
View Fulltext in Publisher
Article
3
Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancer
by
Stenehjem DD
,
Yoo M
,
Unni SK
,
Singhal M
,
Bauer H
,
Saverno K
,
Quah C
,
Masaquel
A
,
Brixner DI
Published 2014-10-01
Get full text
Article
Search Tools:
Get RSS Feed
—
Email this Search
Related Subjects
Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
Article
Biosimilar Pharmaceuticals
Cost-Benefit Analysis
Drug Costs
Humans
Lymphoma, Follicular
Markov Chains
Markov chain
Quality-Adjusted Life Years
Rituximab
United States
adverse event
antineoplastic agent
bendamustine
biosimilar agent
cancer chemotherapy
cost benefit analysis
cost effectiveness analysis
cyclophosphamide
doxorubicin
drug cost
drug efficacy
drug safety
drug utilization
economics
febrile neutropenia
follicular lymphoma
health care cost
Loading...